Directory
>
Sweta Girgenrath
Sweta Girgenrath
Vice President, Head of Cardiovascular and Neuromuscular & Cardiovascular Therapeutics | Entrada Therapeutics
Boston, Massachusetts, United States
Sweta Girgenrath
Summary
Sweta Girgenrath is a seasoned professional with over 15 years of experience in both academia and the pharmaceutical industry, specializing in rare and ultra-rare muscle and cardiac diseases. Currently, she serves as the Vice President and Head of Cardiovascular and Neuromuscular Therapeutic Areas at Entrada Therapeutics in Boston. She possesses a strong background in designing preclinical studies that address complex biological questions, leveraging her expertise in cell biology, molecular biology, and translational research. Sweta has a track record of collaborating closely with patient advocacy groups, ensuring that patient needs are at the forefront of research and therapeutic development. Her work spans various modalities, including biologics and gene therapy, highlighting her versatility in the field. Sweta's academic journey includes a Ph.D. in Biology from Northeastern University, and she has held significant roles at prestigious institutions such as UMass Medical School and Pfizer. Her publications reflect her commitment to advancing the understanding of muscular dystrophies and developing effective treatments.
Sweta Girgenrath
Work Experience
Vice President, Head of Cardiovascular and Neuromuscular & Cardiovascular Therapeutics at
Entrada Therapeutics
January 2023 - Present
Head of Cardiovascular and Neuromuscular Therapeutic areas at
Entrada Therapeutics
December 2020 - Present
Research Associate Professor at
Umass Medical School
January 2016 - Present
Director/Associate Research Fellow in Rare Disease Unit at
Pfizer, Inc.
July 2016 - December 2020
Assistant Professor at
Trustees of Boston University
January 2007 - January 2016
Instructor at
Boston Biomedical Research Institute
August 2005 - October 2007
Postdoctoral Fellow at
Boston Biomedical Research Institute
December 2001 - July 2005
Postdoctoral Fellow at
Brigham and Women's Hospital
January 2001 - November 2001
Postdoctoral Fellow at
The Pennsylvania State University
March 1999 - April 2001
Sweta Girgenrath
Education
Northeastern University, Ph.D
January 1990 - January 1997
Frequently Asked Questions about Sweta Girgenrath
What is Sweta Girgenrath email address?
Sweta Girgenrath's primary email address is ***********@entradatx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Sweta Girgenrath work for?
Sweta Girgenrath is a Vice President, Head of Cardiovascular and Neuromuscular & Cardiovascular Therapeutics at Entrada Therapeutics, a company specializing in Commercial physical research.
Where Sweta Girgenrath graduated from?
Sweta Girgenrath holds a degree in Biology from Northeastern University.
How can I directly contact Sweta Girgenrath?
To contact Sweta Girgenrath directly, you can use the email address ***********@entradatx.com. Complete contact information is available upon registration with Muraena.
Who is Sweta Girgenrath?
Sweta Girgenrath is a seasoned professional with over 15 years of experience in both academia and the pharmaceutical industry, specializing in rare and ultra-rare muscle and cardiac diseases. Currently, she serves as the Vice President and Head of Cardiovascular and Neuromuscular Therapeutic Areas at Entrada Therapeutics in Boston. She possesses a strong background in designing preclinical studies that address complex biological questions, leveraging her expertise in cell biology, molecular biology, and translational research. Sweta has a track record of collaborating closely with patient advocacy groups, ensuring that patient needs are at the forefront of research and therapeutic development. Her work spans various modalities, including biologics and gene therapy, highlighting her versatility in the field. Sweta's academic journey includes a Ph.D. in Biology from Northeastern University, and she has held significant roles at prestigious institutions such as UMass Medical School and Pfizer. Her publications reflect her commitment to advancing the understanding of muscular dystrophies and developing effective treatments.
Sweta`s contact details
***********@entradatx.com
Colleagues
Vice President
Executive Director, FP&A
Executive Director
Chief Financial Officer and Treasurer
Board Member
Co-Founder & Vice President, Discovery Research
Vice President | Head of CMC
President Research And Development at Entrada Therapeutics
President and Chief Operating Officer
VP, Program Governance & Portfolio Management